|
 |
ChlorambucilThis page contains recent news articles, when available, and an overview of Chlorambucil but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Chlorambucil (when available) Chlorambucil is an antineoplastic in the class of alkylating agents and is used to treat various forms of cancer. Alkylating agents are so named because of their ability to add alkyl groups to many electronegative groups under conditions present in cells. They stop tumor growth by cross-linking guanine bases in DNA double-helix strands - directly attacking DNA. This makes the strands unable to uncoil and separate. As this is necessary in DNA replication, the cells can no longer divide. In addition, these drugs add methyl or other alkyl groups onto molecules where they do not belong which in turn inhibits their correct utilization by base pairing and causes a miscoding of DNA. Alkylating agents are cell cycle-nonspecific. Alkylating agents work by three different mechanisms all of which achieve the same end result - disruption of DNA function and cell death. For treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's disease Mechanism Of Action: Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations. News Articles on Chlorambucil Improved survival in advanced stage mantle cell lymphoma - Dec 11, 2009 To strengthen earlier MCL treatment approaches, regimens from the 1970s that used chlorambucil and prednisone or cyclophosphamide, vincristine, ... American Journal of Hemotology and Oncology Les maladies du sang revisitées par les biothérapies - Dec 15, 2009 Nous ne pouvons plus nous contenter de donner seulement un médicament ancien comme le chlorambucil », juge Noël Milpied. La deuxième inconnue est tout aussi ... Les Échos Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced ... - Nov 5, 2009 Efficacy relative to first line therapies other than chlorambucil has not been established. TREANDA received its second approval in October 2008 for the ... Reuters Genmab/GlaxoSmithKline: first approval for Arzerra - Oct 28, 2009 ...study involving refractory CLL patients, Arzerra is currently in Phase III trials for the first-line treatment of CLL in combination with chlorambucil. ... Trading Markets (press release) Celgene Corporation Q3 2009 Earnings Call Transcript - Oct 22, 2009 CLL-008, the origin trial, a global phase III SPA-approved study of REVLIMID versus Chlorambucil in previously untreated elderly patients is the first ... Seeking Alpha (blog) Orange-Yellow Diffuse Cutaneous Eruption in an 82-Year-Old Woman—Diagnosis - Oct 19, 2009 4 Improvements in skin lesions have been reported with the use of corticosteroids, chlorambucil, melphalan, interferon alfa-2a, and local radiation. 5 1. ... Archives of Dermatology Asymptomatic Red Plaque on the Leg of a 7-Year-Old Girl—Diagnosis - Oct 19, 2009 1, 8 Multifocal lesions have been treated with a variety of agents, including systemic or intralesional steroids, interferon alfa, chlorambucil, ... Archives of Dermatology … data shows MabCampath almost 30 pct more effective than chlorambuci... - Jun 4, 2006 Today, chlorambucil is by many considered to offer the most tolerable safety profile for previously untreated patients, Schering siad. ... Forbes … phase III trial on MabCampath reveals superiority to chlorambucil - Dec 11, 2006 FRANKFURT (AFX) - Schering AG said results of a phase III trial show that its MabCampath treatment is superior to chlorambucil for previously-untreated ... Forbes Cephalon's Treanda works in type of leukemia-study - Dec 9, 2007 Treanda, also known as bendamustine, was tested against chlorambucil in the pivotal study, which the company has included in its submission to US health ... Reuters Chlorambucil (Systemic). - Oct 27, 2005 Chlorambucil (klor-AM-byoo-sill) belongs to the group of medicines called alkylating agents. It is used to treat cancer of the blood and lymph system. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Cephalon wins US approval for leukemia drug - Mar 20, 2008 ...of 301 previously untreated CLL patients who were randomly assigned to receive the Cephalon drug or another chemotherapy treatment called chlorambucil. ... Reuters UK Cephalon to file cancer drug sooner than expected - Jun 28, 2007 ...the active ingredient in Treanda, with the chemotherapy chlorambucil in patients with chronic lymphocytic leukemia who have not been previously treated. ... Reuters … Study Show Campath(R) Superior To Chlorambucil As A First-line … - Dec 12, 2006 The study met its primary endpoint by demonstrating superior progression free survival in patients treated with Campath versus chlorambucil, with Campath ... Medical News Today - Medical News Today (press release) Drug Combo Effective Against Leukemia - Jul 19, 2007 In the US, patients are often treated with fludarabine (brand name Fludara) or chlorambucil (brand name Leukeran). In the latest study of CLL drugs, ... WebMD High-dose short-term chlorambucil effective for sympathetic ophthalmia - Jun 3, 2007 High-dose short-term chlorambucil therapy for sympathetic ophthalmia is effective and allows discontinuation of systemic steroids. ... Ophthalmology Times Genmab Announces Upcoming Ofatumumab Studies - Aug 25, 2008 Phase III CLL front line chlorambucil combination This open-label, ... Patients receiving ofatumumab in combination with chlorambucil will receive one ... RedOrbit Final Data From Phase III Study Show Single-Agent Alemtuzumab ( … - Dec 12, 2006 Chlorambucil is a chemotherapy drug that has been used extensively in first-line ... Chlorambucil as Front-Line Therapy for Patients with Progressive B-Cell ... Medical News Today - Medical News Today (press release) Chlorambucil therapy is a highly effective treatment for chronic,... - Mar 24, 2005 SANTIAGO, Chile — A short-term treatment regimen of high-dose chlorambucil appears to be highly effective in patients with chronic and severe anterior ... OSN SuperSite Alemtuzumab Tops Chlorambucil for Therapy-Naive B-Cell Chronic … - Jun 10, 2007 By Jill Stein. VIENNA, AUSTRIA -- June 10, 2007 -- The recombinant, humanised anti-CD52 monoclonal antibody alemtuzumab is superior to chlorambucil in ... DG News NCCN Updates Non-Hodgkin's Lymphoma Guidelines - Apr 22, 2008 39% for chlorambucil with a complete response of 30% vs. 2% for chlorambucil), median progression-free survival (21.7 months vs. ... Genetic Engineering News - Genetic Engineering News (press release) Combination Therapy Increases Response Rates in CLL - Jul 26, 2007 In the current phase 3 trial, combination fludarabine and cyclophosphamide therapy was compared with either fludarabine alone or high-dose chlorambucil (70 ... Medscape FDA Approves TREANDA, a Novel Chemotherapy for Chronic … - Apr 4, 2008 Patients who received TREANDA also had a higher complete response rate than those treated with chlorambucil (8 percent vs. < 1 percent), which means that ... newswise.com New Drug Approved for Chronic Lymphocytic Leukemia - Mar 22, 2008 Fifty-nine percent of the patients taking Treanda had their disease significantly reduced by the drug, compared to 26% of those taking chlorambucil. ... ACS News Center chlorambucil | Definition of chlorambucil | HighBeam.com: Online … - Jul 12, 2006 Find out what chlorambucil means: The Oxford American College Dictionary has the definition of chlorambucil. Research related newspaper, magazine, ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research Analysis of: Alemtuzumab Compared With Chlorambucil As First-Line … - Dec 10, 2007 On paper it sounds good but the chlorambucil is oral once every 28 days vs. IV 3x/week IV x up to 12 weeks. (David v Goliath right? ... Gerson Lehrman Group Treanda approved for chronic lymphocytic leukemia - Mar 27, 2008 Of those taking Treanda 59% showed disease symptoms significantly reduced, compared to 26% those taking chlorambucil (Leukeran®). After receiving the entire ... Cancerfacts.com Invitrogen Features New Scientific Online Resources and Celgene … - Dec 12, 2006 The study compared Campath with chlorambucil in previously untreated patients with B-cell chronic lymphocytic leukemia. The study met its primary endpoint ... Free with registration - M2 Presswire - AccessMyLibrary.com First-Line CAMPATH for CLL: Wide Use Unlikely - Sep 24, 2007 This approval is based on a comparison with Chlorambucil, an agent not commonly used for first line treatment in the United States. ... Gerson Lehrman Group A new drug improves long term survival for mantle cell lymphoma - Jul 2, 2007 The usual treatment is MCP(mitoxantrone, chlorambucil, and prednisolone), a type of chemotherapy. The Journal of Clinical Oncology found that by adding ... TopCancerNews.com Press Release: Final Data from Phase III Study Show Single-Agent … - Dec 11, 2006 Final Data from Phase III Study Show Single-Agent Alemtuzumab (Campath(R), MabCampath(R)) Superior to Chlorambucil for Patients with Previously Untreated ... Pay-Per-View - PR Newswire - HighBeam Research Bendamustine Effective as First-Line Treatment in B-Cell Chronic … - Dec 8, 2008 Patients in the second treatment cohort (n = 157) received chlorambucil (0.8 mg/kg ... [Presentation title: Bendamustine Versus Chlorambucil as First-Line ... DG News Press Release: Final Data from Phase III Study Show Single-Agent … - Dec 12, 2006 Final Data from Phase III Study Show Single-Agent Alemtuzumab (MabCampath(R)) Superior to Chlorambucil for Patients with Previously Untreated B-CLL. from PR ... Pay-Per-View - PR Newswire Europe - HighBeam Research Genmab Announces Upcoming Ofatumumab Studies - Aug 24, 2008 Phase III CLL front line chlorambucil combination This open-label, ... Patients receiving ofatumumab in combination with chlorambucil will receive one ... Genetic Engineering News - Genetic Engineering News (press release) Alemtuzumab Safe, Effective First-Line Treatment for Chronic … - Dec 26, 2007 The median length of chlorambucil exposure was 28.3 weeks, median cumulative dose 515 mg. "Alemtuzumab was superior to chlorambucil as measured by ... Cancerpage.com Re-induction of hormonal sensitivity in hormone-refractory prostate … - Feb 14, 2005 ...(2005) Chlorambucil and lomustine (CL56) in absolute hormone refractory ... 1 These patients were treated in a phase II trial of chlorambucil and lomustine. ... Nature.com New Phase III Study Shows Strong Efficacy and Favorable Safety... - Jun 6, 2006 The complete response (CR) was 24 percent for MabCampath versus two percent for chlorambucil (p = less than 0.0001). Currently, chlorambucil is considered ... presseportal.de Press Release: Genmab Announces Upcoming Ofatumumab Studies. - … - Aug 25, 2008 Phase III CLL front line chlorambucil combination This open-label, ... Patients receiving ofatumumab in combination with chlorambucil will receive one ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Genzyme and Berlex Oncology Announce Interim Results … - Jun 3, 2006 The open-label, randomized trial with 297 patients compared the efficacy and safety of Campath to chlorambucil, which is considered by many to offer the ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: TREANDA Significantly Improves Clinical Outcomes in … - Dec 10, 2007 ..."In this study, bendamustine was more effective than chlorambucil in achieving remissions in treatment-naive patients with CLL," said Dr. Wolfgang Knauf, ... Pay-Per-View - PR Newswire - HighBeam Research New Phase III Study Shows Strong Efficacy and Favorable Safety... - Jun 5, 2006 The complete response (CR) was 24 percent for MabCampath versus two percent for chlorambucil (p = less than 0.0001). Currently, chlorambucil is considered ... Free with registration - PR Newswire - AccessMyLibrary.com Systemic juvenile idiopathic arthritis: diagnosis, management, and … - Jul 21, 2005 Chlorambucil is an effective treatment for halting the progression of amyloidosis; however, the increased risk of lymphoma with chlorambucil therapy is a ... Nature.com Broad label for new leukemia therapy looks promising. - May 12, 2008 The product's label states, however, that bendamustine's efficacy relative to first-line therapies other than chlorambucil has not been established. ... $9.94 - Drug Topics - Alacra Store Campath shown to be more effective against leukemia than standard drug - Jun 30, 2006 Researchers examined the safety, response rate and overall survival of patients who took Campath and patients who took chlorambucil. ... Bizjournals.com Bayer AG | Chronisch-lymphatische Leukämie vom B-Zell-Typ | … - Oct 23, 2007 ...andauerte als bei den Patienten der Chlorambucil-Gruppe: MabCampath reduzierte das Risiko des Fortschreitens der Krankheit oder Todes um 42 Prozent. ... pressrelations.de Phase-III-Studie mit CAM307 - Dec 11, 2006 Verglichen wurde MabCampath® (Alemtuzumab) mit Chlorambucil bei noch nicht vorbehandelten Patienten mit chronisch-lymphatischer B-Zell-Leukämie (B-CLL). ... Lifegen.de - Lifegen.de (Abonnement) Genmab anuncia los próximos estudios de ofatumumab - Aug 25, 2008 Combinación de chlorambucil de primera lÃnea CLL de Fase III Este ensayo de brazo paralelo de etiqueta abierta incluirá a 444 pacientes con CLL ... Finanzas.com Alemtuzumab as first-line therapy for B-cell chronic lymphocytic... - Oct 19, 2006 The OR rate in 39 patients who received chlorambucil was 41% (0% CR) (P<0.001 vs alemtuzumab) and 70% (10% CR) in 30 patients who received purine analogs as ... Nature.com Press Release: Genzyme Files for Expanded Label for Campath(R) as … - Apr 4, 2007 1) These data showed alemtuzumab (Campath(R), MabCampath(R)) was superior to chlorambucil as ... chemotherapy drug that has been used extensively in ... Pay-Per-View - PR Newswire - HighBeam Research Imatinib induces apoptosis in CLL lymphocytes with high expression of... - Apr 7, 2005 With interest we read the results presented by Aloyz R et al 1 regarding the sensitizing effect of Imatinib on CLL lymphocytes treated with Chlorambucil. ... Nature.com FDA approves TREANDA (bendamustine hydrochloride) for chronic … - Apr 7, 2008 Patients who received TREANDA also had a higher complete response rate than those treated with chlorambucil (8 percent vs. < 1 percent), which means that ... News-Medical.net FDA Approves Expanded Labeling for Campath(R) to Include First-line … - Sep 20, 2007 The study met its primary endpoint by demonstrating longer progression free survival (PFS) in patients treated with Campath versus chlorambucil, ... Free with registration - PR Newswire - AccessMyLibrary.com Cyclophosphamide followed by fludarabine for untreated chronic … - Sep 29, 2005 Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000; 343: 1750−1757. ... Nature.com Press Release: New Phase III Study Shows Strong Efficacy and … - Jun 6, 2006 The complete response (CR) was 24 percent for MabCampath versus two percent for chlorambucil (p = less than 0.0001). Currently, chlorambucil is considered ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: New Phase III Study Shows Strong Efficacy and … - Jun 5, 2006 The complete response (CR) was 24 percent for MabCampath versus two percent for chlorambucil (p = less than 0.0001). Currently, chlorambucil is considered ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Cephalon Receives FDA Approval for TREANDA, a Novel … - Mar 20, 2008 3 study demonstrating that TREANDA (bendamustine HCl) for Injection ... chlorambucil in patients with chronic lymphocytic leukemia (CLL). Results of this . ... Pay-Per-View - PR Newswire - HighBeam Research Non ‐ corticosteroid treatment for nephrotic syndrome in... - Jul 1, 2007 In the single chlorambucil versus cyclophosphamide trial, ... Eight week courses of cyclophosphamide or chlorambucil and prolonged courses of cyclosporin ... Medscape Preliminary studies show promise in drug for treating leukemia - Aug 4, 2006 Researchers examined the safety, response rate and overall survival of patients who took Campath and patients who took chlorambucil. ... San Antonio Business Journal macroglobulinemia, fludarabine, cyclophosphamide - Mar 25, 2005 1 Long-term therapy usually consists of low-dose chlorambucil, although both daily low-dose schedules and intermittent high-dose schedules have been used. ... Nature.com Genmab annonce la tenue imminente d'études sur l'ofatumumab - Aug 25, 2008 Étude de phase III sur le traitement de première ligne en association avec le chlorambucil : cette étude ouverte à groupes parallèles comprendra 444 ... Caducée.net Press Release: FDA Approves Expanded Labeling for Campath(R) to … - Sep 20, 2007 The study met its primary endpoint by demonstrating longer progression free survival (PFS) in patients treated with Campath versus chlorambucil, ... Pay-Per-View - PR Newswire - HighBeam Research Risk stratification for survival and leukemic transformation in... - Dec 14, 2006 When employed, specific treatment agents included hydroxyurea, anagrelide, interferon alpha, busulfan, chlorambucil and radiophosphorus (P-32). ... Nature.com MabCampath Available For First Line Treatment Of B-Cell Chronic … - Feb 19, 2008 The first line licence has been granted based on data from an international open-label Phase 3 clinical trial comparing MabCampath® with chlorambucil in ... Medical News Today - Medical News Today (press release) SLE in the cat: clinical signs vary dramatically.(DERMATOLOGY) - Sep 1, 2005 Administration of chlorambucil was again recommended, but the owner declined. Prednisone was re-initiated. Ultimately, clinical remission was maintained ... Free with registration - DVM Newsmagazine - AccessMyLibrary.com New standard treatment for the most common form of leukemia in adults - Jul 31, 2007 The drugs used to treat CLL consist of Fludara, Cytoxan and chlorambucil. ... Patients treated with chlorambucil had a 72 percent anticancer response. ... TopCancerNews.com Pilot trial in membranous nephropathy - Feb 28, 2006 His group has published three previous controlled trials [ 2 , 3 , 4 ] of methylprednisolone alternated with either chlorambucil or cyclophosphamide every ... Medscape MabCampath® Receives Positive Opinion from European Committee for … - Oct 25, 2007 The CHMP positive opinion was based on data from an international open-label Phase 3 clinical trial comparing MabCampath with chlorambucil in previously ... webwire.com Secondary cancers in leukemia - May 9, 2005 Most of these patients with AML had previous treatment with Chlorambucil, an alkylating ... The emergence of AML can be minimized by avoiding Chlorambucil. ... sptimes.com Genzyme seeks expanded FDA approval for Campath - Apr 4, 2007 Chlorambucil is currently the standard first-line treatment. Campath was developed in San Antonio by ILEX Oncology Inc., which merged with Genzyme in 2004. ... Bizjournals.com FDA clears Cephalon's Treanda for CLL. - Mar 31, 2008 Those who received Treanda also had a higher complete response rate than chlorambucil patients (8% vs less than 1%), which means that, after treatment, ... $9.94 - Pharma Marketletter - Alacra Store Re-induction of hormone sensitivity to diethylstilboestrol in... - Jan 8, 2008 Shamash J, Dancey G, Barlow C, Wilson P, Ansell W, Oliver RT (2005) Chlorambucil and lomustine (CL56) in absolute hormone-refractory prostate cancer: ... Nature.com Alemtuzumab bereichert die Leukämietherapie - Jul 6, 2007 Auch die progressionsfreie Lebenszeit war nach Therapie mit dem Antikörper Alemtuzumab (MabCampath®) hochsignifikant länger als nach Chlorambucil-Therapie. ... Ärzte Zeitung DESPATCH FROM 'THE PLANET OF THE ILL'. - Feb 8, 2005 WHEN that point arrived in June 2002, I was given chlorambucil, ... The violent negative reaction I had to chlorambucil had an equally violent positive ... Pay-Per-View - Evening Standard - Factiva, from Dow Jones FDA erweitert die Zulassung von Campath® in den USA - Sep 24, 2007 Die Unterschiede gegenüber den Patienten unter Chlorambucil waren statistisch signifikant. Die Nebenwirkungen von Campath waren beherrschbar. ... Lifegen.de - Lifegen.de (Abonnement) Завершена III фаза клиничеÑ?кого иÑ?Ñ?ледованиÑ? ЛС Treanda в терапии - Dec 10, 2007 Ð’ группе, получавшей ЛС Treanda, полнаÑ? ремиÑ?Ñ?иÑ? отмечалаÑ?ÑŒ у 68% пациентов, в группе, получавшей chlorambucil, - у 39%. Также компаниÑ? изучает клиничеÑ?кую ... ФармацевтичеÑ?кий веÑ?тник Gentest erleichtert Therapie-Entscheidung bei CLL - Jan 23, 2008 Konventionelle Chemotherapien, entweder mit Alkylantien wie Chlorambucil oder mit ... Unter Chlorambucil lag die Ansprechrate bei 55 Prozent und die Rate ... Ärzte Zeitung Leukämiepräparat MabCampath erhält Zulassungserweiterung in Europa - Jan 8, 2008 ...bei bisher unbehandelten B-CLL-Patienten mit Chlorambucil verglichen wurde. ... als bei den Patienten der Chlorambucil-Gruppe: MabCampath reduzierte das ... chemie.de TREANDA New Drug Application for the Treatment of Chronic … - Dec 3, 2007 Chlorambucil, a chemotherapy drug, is FDA-approved as a first-line therapy for patients with CLL. In the pivotal trial, bendamustine HCl met both primary ... Free with registration - PR Newswire - AccessMyLibrary.com Cephalon Submits New Drug Application For TREANDA For The … - Sep 22, 2007 Chlorambucil is an FDA-approved first- line therapy for patients with CLL. In the pivotal trial, bendamustine HCl met both primary endpoints, ... Medical News Today - Medical News Today (press release) Bendamustine Added to US Treatment Guidelines for Leukaemia, … - Apr 24, 2008 At a median follow-up of 18.5 months, bendamustine, in comparison with chlorambucil, produced a significantly higher overall response rate (68% vs 39%), ... DG News Genzyme's third-quarter earnings tumble, charges offset sales growth - Oct 12, 2006 Chlorambucil is currently the standard treatment for these type of patients. Genzyme will release its findings at the American Society of Hematology meeting ... San Antonio Business Journal Phase III data presented at the ASH Meeting showed Campath ( … - Feb 1, 2007 Phase III data presented at the ASH Meeting showed Campath (alemtuzumab) demonstrated superior progression-free survival versus chlorambucil in previously ... Free with registration - Applied Clinical Trials - AccessMyLibrary.com Developments in the Treatment of Chronic Lymphocytic Leukemia (CLL): ... - Jun 2, 2006 A very interesting study was presented by Hillmen et al. that compared Campath® (alemtuzumab) (30 mg tiw up to 12 weeks) with Leukeran® (chlorambucil) (40 ... Cancer Consultants TREANDA for CLL could be a winner - May 19, 2008 The ease of use compared to fludarabine regimens, and the superior efficacy vs chlorambucil, puts TREANDA in the sweet spot for potential front-line use in ... Gerson Lehrman Group USA biotech: Rituxan in meets leukemia goal - Oct 8, 2008 That approval was based on a 301-patient study showing a higher overall response compared to standard chemo agent chlorambucil. That study also showed ... $34.00 - EIU Country Analysis - Alacra Store Genmab/Roche: LægemiddelhÃ¥b bliver nicheprodukt og hurtigt forældet - Dec 8, 2008 Ã…rsagen er, at Chlorambucil ikke bruges til de sygeste patienter, der i stedet fÃ¥r den meget giftigere og ogsÃ¥ mere virksomme cocktail af kemoterapiformerne ... TV2 A brief primer on treatments of cutaneous T cell lymphoma, newly … - Jul 1, 2007 Metastatic disease has been treated with radiotherapy, extracorporeal photophoresis, and old line chemotherapy agents such as methotrexate, chlorambucil, ... $4.95 - Journal of Drugs in Dermatology - ECNext Searing eye pain needs a closer look--and soon - Feb 27, 2005 A recent study showed that patients who weren't improving with steroids and received the immunosuppression drugs chlorambucil or cyclophosphamide improved ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Is it immune-mediated neutropenia? Since no test definitively... - Nov 1, 2007 Azathioprine and chlorambucil Azathioprine at 2 mg/kg daily for one week ... If additional immune suppression is needed in cats, chlorambucil can be given. ... Free with registration - Veterinary Medicine - AccessMyLibrary.com Chemoimmunotherapy—towards real progress in the treatment of chronic … - Mar 8, 2005 ...who were enrolled, from 1990 to 1994, on the fludarabine-only arm of the CALGB 9011 trial, which compared fludarabine with chlorambucil or both drugs. ... Nature.com FOCUS Bayer's HealthCare division to suffer from pipeline delays - … - Dec 11, 2006 Schering today reported results of a phase III trial revealing that its MabCampath treatment is superior to chlorambucil for previously-untreated patients ... Forbes John Libbey Eurotext : Éditions médicales et scientifiques France :... - May 16, 2007 Un traitement par 4 cures discontinues de chlorambucil (Chloraminophène ® , 1 comprimé pour 10 kg de poids corporel pendant 5 jours) est instauré de mars à ... john-libbey-eurotext.fr EU agency backs Bayer, Genzyme leukemia drug - Oct 23, 2007 The CHMP's opinion was based on data from a late study comparing MabCampath with chlorambucil in previously untreated B-CLL patients. ... Reuters Myelodysplastic syndromes - Oct 13, 2007 ...clear-cut cause of myelodysplastic syndromes is treatment with certain chemotherapy drugs, among them mechlorethamine, procarbazine and chlorambucil. ... CNN Loss of Zap-70 and low molecular weight phosphotyrosine phosphatase … - Jun 2, 2005 She was treated with six cycles of chlorambucil and prednisone with a partial response in lymphocyte count, spleen size, and lymph node shrinkage. ... Nature.com High incidence of late effects found in Hodgkin's lymphoma survivors,... - Nov 15, 2005 Of whom, 42 (72%) also received chemotherapy (10 different regimens, the most frequent being LOPP (LOPP=Chlorambucil, Vincristine, Procarbazine, ... Nature.com Chronic lymphocytic leukaemia, synchronous small cell carcinoma and … - Aug 30, 2005 After 20 years, he developed chronic lymphocytic leukaemia, which was treated with chlorambucil and fludarabine. After 2 years, investigation of bilateral ... Nature.com Hybrid drugs may help children with leukaemia - Jul 20, 2007 Institute of Cancer Research doctors in Britain found that fludarabine (marketed as Fludara) and chlorambucil (Leukeran), when used together, were no better ... Independent Online High ZAP-70 expression correlates with worse clinical outcome in... - Aug 17, 2006 32 of the 64 patients received CHOP-based (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy, 15 had chlorambucil-based chemotherapy, ... Nature.com Alemtuzumab in combination with high-dose methylprednisolone is a … - Jun 1, 2006 4 Recent analysis of the UK CLL4 trial comparing chlorambucil with F and FC (fludarabine and fludarabine plus cyclophosphamide, respectively) has shown that ... Nature.com Cytomegalovirus retinitis in chronic lymphocytic leukaemia - Aug 18, 2006 She was known to suffer from CLL for 2.5 years and had been treated with two courses of chemotherapy (chlorambucil, fludarabine, and prednisolone). ... Nature.com How It Works - Apr 22, 2008 Fludarabine is an effective treatment for chronic lymphocytic leukemia (CLL) that has not responded to other types of chemotherapy, such as chlorambucil or ... WebMD Survival from adult leukaemia in England and Wales up to 2001 - Sep 23, 2008 When treatment is needed, UK practice has been to use chlorambucil; however, a recent trial indicated that better and more durable disease responses can be ... Nature.com Leukemia - Autoimmune hemolytic anemias and IgG antierythrocyte … - Apr 6, 2006 First-line therapy included chlorambucil (39 patients), combination chemotherapy (2), fludarabine alone (6) or in combination with other chemotherapy (3), ... Nature.com Michael Aspel on saying no to cancer treatment - Jan 29, 2007 Every day for a fortnight he took 10ml of Chlorambucil in tablet form - then had two weeks off, the cycle lasting for around three months. ... Daily Mail The role of the bax gene polymorphism G(-248)A in chronic lymphocytic... - Jun 8, 2006 Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2 expressing subclones. ... Nature.com Cancer Health Center - Nov 26, 2008 Other drug choices include fludarabine, chlorambucil, hydroxyurea (hydroxycarbamide), cytarabine, busulfan, rituximab, and alemtuzumab. ... WebMD Brand Names/Synonyms: Chlorambucil is also known by the following brand names and/or synonymsAmbochlorin; Amboclorin; CB 1348; Cb L348; Chlocambucil; Chlorambucil; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chloroambucil; Chlorobutin; Chlorobutine; Ecloril; Elcoril; Leukeran; Leukeran Tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; NSC 3088; Pepstatin; Phenylbuttersaeure-Lost; Phenylbutyric Acid Nitrogen Mustard; Rcra Waste Number U035 Drug Category: Chlorambucil is categorized under the following by the FDA: Antineoplastic Agents; ATC:L01AA02 Dosage Forms: TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |